R
Roberto Orozco
Researcher at Hospital General San Juan de Dios
Publications - 40
Citations - 2897
Roberto Orozco is an academic researcher from Hospital General San Juan de Dios. The author has contributed to research in topics: Biopsy & Prostate cancer. The author has an hindex of 17, co-authored 40 publications receiving 2590 citations. Previous affiliations of Roberto Orozco include University of Michigan & University of Alberta.
Papers
More filters
Journal ArticleDOI
The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia
John R. Srigley,Brett Delahunt,John N. Eble,Lars Egevad,Jonathan I. Epstein,David J. Grignon,Ondrej Hes,Holger Moch,Rodolfo Montironi,Satish K. Tickoo,Ming Zhou,Pedram Argani,Anila Abraham,Adebowale J. Adeniran,Khalid Ahmed,Hikmat Al Ahmadie,Ferran Algaba,Robert W. Allan,Mahul B. Amin,Ulrika Axcrona,Marc Barry,Dilek Ertoy Baydar,Louis R. Bégin,Daniel M. Berney,Peter Bethwaite,Athanase Billis,Ruth Birbe,Stephen M. Bonsib,David G. Bostwick,Fadi Brimo,Helen P. Cathro,Ying-Bei Chen,Liang Cheng,John C. Cheville,Yong Mee Cho,Ai Ying Chuang,Cynthia Cohen,Henry Crist,Warick Delprado,Fang Ming Deng,Andrew Evans,Oluwole Fadare,Daniel A. Fajardo,Sara M. Falzarano,Samson W. Fine,Stewart Fleming,Eddie Fridman,Bungo Furusato,Masoud Ganji,Masoumeh Ghayouri,Giovanna A. Giannico,Neriman Gokden,David J. Griffiths,Nilesh S. Gupta,Omar Hameed,Michelle S. Hirsch,Jiaoti Huang,Wei Huang,Christina Hulsbergen Van De Kaa,Peter A. Humphrey,Sundus Hussein,Kenneth A. Iczkowski,Rafael E. Jimenez,Edward C. Jones,Laura Irene Jufe,James G. Kench,Masatoshi Kida,Glen Kristiansen,Lakshmi P. Kunju,Zhaoli Lane,Mathieu Latour,Claudio Lewin,Kathrine Lie,Josep Lloreta,Barbara Loftus,Antonio Lopez-Beltran,Fiona Maclean,Cristina Magi-Galluzzi,Guido Martignoni,Teresa McHale,Jesse K. McKenney,Maria Merino,Rose Miller,Hiroshi Miyamoto,Hedwig Murphy,John N. Nacey,Tipu Nazeer,Gabriella Nesi,George J. Netto,Peter W. Nichols,Marie O'Donnell,Semra Olgac,Roberto Orozco,Adeboye O. Osunkoya,Aysim Ozagari,Chin Chen Pan,Anil V. Parwani,Joanna Perry-Keene,Constantina Petraki,Maria M. Picken,Maria Pyda-Karwicka,Victor E. Reuter,Katayoon Rezaei,Nathalie Rioux-Leclercq,Brian D. Robinson,Stephen Rohan,Ruben Ronchetti,Laurie Russell,Hemamali Samaratunga,Marina Scarpelli,Ahmed Shabaik,Rajal B. Shah,Jonathan H Shanks,Steven S. Shen,Maria Shevchuk,Mathilde Sibony,Bhuvana Srinivasan,Martin Susani,Sueli Suzigan,Joan Sweet,Hiroyuki Takahashi,Pheroze Tamboli,Puay Hoon Tan,Isabel Trias,Kiril Trpkov,Larry True,Toyonori Tsuzuki,Funda Vakar-Lopez,Theo H. van der Kwast,Cheng Wang,Anne Y. Warren,Jorge L. Yao,Asli Yilmaz,Jin Zhao,Debra L. Zynger +134 more
TL;DR: The classification working group of the International Society of Urological Pathology consensus conference on renal neoplasia was in charge of making recommendations regarding additions and changes to the current World Health Organization Classification of Renal Tumors, with consensus that 5 entities should be recognized as new distinct epithelial tumors within the classification system.
Journal ArticleDOI
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
Brett Delahunt,John C. Cheville,Guido Martignoni,Peter A. Humphrey,Cristina Magi-Galluzzi,Jesse K. McKenney,Lars Egevad,Ferran Algaba,Holger Moch,David J. Grignon,Rodolfo Montironi,John R. Srigley,John R. Srigley,Anila Abraham,Adebowale J. Adeniran,Khalid Ahmed,Hikmat Al Ahmadie,Robert W. Allan,Mahul B. Amin,Pedram Argani,Ulrika Axcrona,Marc Barry,Dilek Ertoy Baydar,Louis R. Bégin,Daniel M. Berney,Peter Bethwaite,Athanase Billis,Ruth Birbe,Stephen M. Bonsib,David G. Bostwick,Fadi Brimo,Helen P. Cathro,Ying-Bei Chen,Liang Cheng,Yong Mee Cho,Ai Ying Chuang,Cynthia Cohen,Henry Crist,Warick Delprado,Fang Ming Deng,Jonathan I. Epstein,Andrew Evans,Oluwole Fadare,Daniel A. Fajardo,Sara M. Falzarano,Samson W. Fine,Stewart Fleming,Eddie Fridman,Bungo Furusato,Masoud Ganji,Masoumeh Ghayouri,Giovanna A. Giannico,Neriman Gokden,David J. Griffiths,Nilesh S. Gupta,Omar Hameed,Ondrej Hes,Michelle S. Hirsch,Jiaoti Huang,Wei Huang,Christina Hulsbergen Van De Kaa,Sundus Hussein,Kenneth A. Iczkowski,Rafael E. Jimenez,Edward C. Jones,Laura Irene Jufe,James G. Kench,Masatoshi Kida,Glen Kristiansen,Lakshmi P. Kunju,Zhaoli Lane,Mathieu Latour,Claudio Lewin,Kathrine Lie,Josep Lloreta,Barbara Loftus,Antonio Lopez-Beltran,Fiona Maclean,Teresa McHale,Maria Merino,Rose Miller,Hiroshi Miyamoto,Hedwig Murphy,John N. Nacey,Tipu Nazeer,Gabriella Nesi,George J. Netto,Peter W. Nichols,Marie O'Donnell,Semra Olgac,Roberto Orozco,Adeboye O. Osunkoya,Aysim Ozagari,Chin Chen Pan,Anil V. Parwani,Joanna Perry-Keene,Constantina Petraki,Maria M. Picken,Maria Pyda-Karwicka,Victor E. Reuter,Katayoon Rezaei,Nathalie Rioux-Leclercq,Brian D. Robinson,Stephen Rohan,Ruben Ronchetti,Laurie Russell,Marina Scarpelli,Ahmed Shabaik,Rajal B. Shah,Jonathan H Shanks,Steven S. Shen,Maria Shevchuk,Mathilde Sibony,Bhuvana Srinivasan,Martin Susani,Sueli Suzigan,Joan Sweet,Hiroyuki Takahashi,Puay Hoon Tan,Satish K. Tickoo,Isabel Trias,Larry True,Toyonori Tsuzuki,Funda Vakar-Lopez,Theo H. van der Kwast,Cheng Wang,Anne Y. Warren,Jorge L. Yao,Asli Yilmaz,Jin Zhao,Ming Zhou,Debra L. Zynger +131 more
TL;DR: The International Society of Urological Pathology 2012 Consensus Conference made recommendations regarding classification, prognostic factors, staging, and immunohistochemical and molecular assessment of adult renal tumors.
Journal ArticleDOI
Analysis of repeated biopsy results within 1 year after a noncancer diagnosis.
TL;DR: A multivariate logistic regression algorithm was constructed using the patients' age, initial biopsy diagnosis, total PSA, and free/total PSA ratio that could predict the likelihood of cancer on the repeated biopsy with an accuracy of 70%.
Journal ArticleDOI
Renal tumors: diagnostic and prognostic biomarkers.
Puay Hoon Tan,Liang Cheng,Nathalie Rioux-Leclercq,Maria J. Merino,George J. Netto,Victor E. Reuter,Steven S. Shen,David J. Grignon,Rodolfo Montironi,Lars Egevad,John R. Srigley,Brett Delahunt,Holger Moch,Anila Abraham,Adebowale J. Adeniran,Khalid Ahmed,Hikmat Al Ahmadie,Ferran Algaba,Robert W. Allan,Mahul B. Amin,Pedram Argani,Ulrika Axcrona,Marc Barry,Dilek Ertoy Baydar,Louis R. Bégin,Daniel M. Berney,Peter Bethwaite,Athanase Billis,Ruth Birbe,Stephen M. Bonsib,David G. Bostwick,Fadi Brimo,Helen P. Cathro,Ying-Bei Chen,John C. Cheville,Yong Mee Cho,Ai Ying Chuang,Cynthia Cohen,Henry Crist,Warick Delprado,Fang Ming Deng,Jonathan I. Epstein,Andrew Evans,Oluwole Fadare,Daniel A. Fajardo,Sara M. Falzarano,Samson W. Fine,Stewart Fleming,Eddie Fridman,Bungo Furusato,Masoud Ganji,Masoumeh Ghayouri,Giovanna A. Giannico,Neriman Gokden,David J. Griffiths,Nilesh S. Gupta,Omar Hameed,Ondrej Hes,Michelle S. Hirsch,Jiaoti Huang,Wei Huang,Christina Hulsbergen Van De Kaa,Peter A. Humphrey,Sundus Hussein,Kenneth A. Iczkowski,Rafael E. Jimenez,Edward C. Jones,Laura Irene Jufe,James G. Kench,Masatoshi Kida,Glen Kristiansen,Lakshmi P. Kunju,Zhaoli Lane,Mathieu Latour,Claudio Lewin,Kathrine Lie,Josep Lloreta,Barbara Loftus,Antonio Lopez-Beltran,Fiona Maclean,Cristina Magi-Galluzzi,Guido Martignoni,Teresa McHale,Jesse K. McKenney,Rose Miller,Hiroshi Miyamoto,Hedwig Murphy,John N. Nacey,Tipu Nazeer,Gabriella Nesi,Peter W. Nichols,Marie O'Donnell,Semra Olgac,Roberto Orozco,Adeboye O. Osunkoya,Aysim Ozagari,Chin Chen Pan,Anil V. Parwani,Joanna Perry-Keene,Constantina Petraki,Maria M. Picken,Maria Pyda-Karwicka,Katayoon Rezaei,Brian D. Robinson,Stephen Rohan,Ruben Ronchetti,Laurie Russell,Hemamali Samaratunga,Marina Scarpelli,Ahmed Shabaik,Rajal B. Shah,Jonathan H Shanks,Maria Shevchuk,Mathilde Sibony,Bhuvana Srinivasan,Martin Susani,Sueli Suzigan,Joan Sweet,Hiroyuki Takahashi,Pheroze Tamboli,Satish K. Tickoo,Isabel Trias,Kiril Trpkov,Larry True,Toyonori Tsuzuki,Funda Vakar-Lopez,Theo H. van der Kwast,Cheng Wang,Anne Y. Warren,Jorge L. Yao,Asli Yilmaz,Jin Zhao,Ming Zhou,Debra L. Zynger +133 more
TL;DR: The role of biomarkers in the diagnosis and assessment of prognosis of renal tumors is addressed and the use of immunohistochemical markers and the approach to specific differential diagnostic scenarios is focused upon.
Journal ArticleDOI
Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer
Kenneth A. Iczkowski,Thomas J. Bassler,Valerie S Schwob,Ilene C. Bassler,Binitha Kunnel,Roberto Orozco,David G. Bostwick +6 more
TL;DR: The high predictive value of ASAP for subsequent adenocarcinoma warrants repeat biopsy and should include multiple sites in the prostate.